Lactic acid bacteria capable of stimulating mucosal immunity
AssigneeOtsuka Pharmaceutical Co., Ltd.
InventorsSatoko Yamahira, Masamichi Toba, Hiroshi Okamatsu
Life of this patent
Estimating the term…
Abstract
The invention provides lactic acid bacteria selected from the group consisting of lactobacillus ONRIC b0239 (FERM BP-10064) and lactobacillus ONRIC b0240 (FERM BP-10065), and compositions containing the bacteria, the compositions being capable of stimulating mucosal immunity, and more specifically, the compositions in the form of foods or beverages or pharmaceutical products. The lactic acid bacteria and compositions containing the bacteria are capable of providing excellent mucosal immunostimulation effects and are useful for reinforcing the host defense system.
Claims5
A composition comprising a strain of lactic acid bacteria selected from the group consisting of a biologically pure culture of Lactobacillus plantarum ONRIC b0239 (FERM BP-10064) and a biologically pure culture of Lactobacillus pentosus ONRIC b0240 (FERM BP-10065), in an amount of at least 106 cells/g of the composition and an edible carrier, wherein the composition is in the form of a food or beverage for a mammal.
A pharmaceutical composition for human mucosal immunostimulation comprising a strain of lactic acid bacteria selected from the group consisting of a biologically pure culture of Lactobacillus plantarum ONRIC b0239 (FERM BP-10064) and a biologically pure culture of Lactobacillus pentosus ONRIC b0240 (FERM BP-10065), in an amount of at least 106 cells/g of the composition and a pharmaceutically acceptable excipient or diluent.
A pharmaceutical composition for promoting human IgA production comprising a strain of lactic acid bacteria selected from the group consisting of a biologically pure culture of Lactobacillus plantarum ONRIC b0239 (FERM BP-10064) and a biologically pure culture of Lactobacillus pentosus ONRIC b0240 (FERM BP-10065), in an amount of at least 106 cells/g of the composition and a pharmaceutically acceptable excipient or diluent.
Dependencies are inferred from the claim text.